MedPath

Safety of fecal microbiota transplantation for steroid-refractory/dependent acute graft-versus-host disease of the gut, a phase I trial

Not Applicable
Recruiting
Conditions
Steroid refractory/dependent acute graft-versus-host disease of gut after allogeneic hematopoietic stem cell transplantation or donor lymphocyte infusion
Registration Number
JPRN-UMIN000053473
Lead Sponsor
Hamanomachi hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1) Steroid sensitive aGVHD. 2) Progressive aGVHD, in which affected organ is irrelevant. 3) Uncontrollable infection. 4) Patients symptoms are considered to be caused mainly by enteropathy other than gut aGVHD. 5) PS 3 or higher. 6) Patients at high risk of aspiration. 7) Inadequate condition judged by primary physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of adverse events that occurred or worsened within 1 week after FMT
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath